Imugene share price
WebApr 12, 2024 · Imugene - IMU Stock Forecast, Price & News Compare Today's Range N/A 50-Day Range N/A 52-Week Range N/A Volume 12.70 million shs Average Volume N/A … WebMar 26, 2024 · It hasn't been the best quarter for Imugene Limited ( ASX:IMU) shareholders, since the share price has fallen 10% in that time. But that doesn't change the fact that the …
Imugene share price
Did you know?
WebASX IMU : Imugene Limited stock forecast, predictions, and share price target for 2024, 2024 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis. year Average Low ... The Imugene Limited stock price forecast for 2024 Mar. is 0.13090714719246. Is Imugene Limited stock a good buy now? ... WebImugene is a publicly traded company, listed on the Australian Securities Exchange (ASX) under the code IMU. In December 2024 it entered the S&P/ASX 200 Index, in effect making …
WebAug 25, 2024 · Its share price surged over 20x in less than 24 months – from 3c in early 2024 to 67c by November 2024 – taking the valuation to an eye-watering $3.3 billion and earning the company ‘unicorn’ status. It also made Imugene the second-biggest ASX drug developer by market cap, behind only CSL. WebImugene Limited Follow Share $0.12 Mar 14, 3:07:39 PM GMT+11 · AUD · ASX · Disclaimer search Compare to Immutep Ltd $0.26 IMM1.89% Sayona Mining Ltd $0.21 SYA8.00% …
WebView today’s IMU share price, options, bonds, hybrids and warrants. View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer analysis … WebJul 29, 2024 · The share price represents a 9.1% discount to the closing price of IMU shares on July 26 and a 10% discount to the five-day volume-weighted average price up to and including that same date.
WebPrice trends tend to persist, so it's worth looking at them when it comes to a share like Imugene. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by-32.6%. As of the last closing price of AU$0.14, shares in Imugene were trading-24.26% below their 200 day moving average.
WebJan 10, 2024 · Imugene Ltd. (IUGNF) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. gcp talk to speechdays until july 31 2023WebApr 11, 2024 · Summary of all time highs, changes and price drops for Imugene; Historical stock prices; Current Share Price: AU$0.13: 52 Week High: AU$0.32: 52 Week Low: … days until july 7th 2023WebImugene Limited (IUGNF) Other OTC - Other OTC Delayed Price. Currency in USD Follow 0.1077 +0.0077 (+7.70%) At close: 03:54PM EDT 1d 5d 1m 6m YTD 1y 5y Max Full screen … gcp teamsWebPrice: Single User License: US $ 3260 . Corporate User License: US $ 6520 . Buy Now. Like . Inquire for Discount Download PDF Request Sample. Report Description; Table of Contents; The Nucleic Acid-based Drugs market revenue was XX Million USD in 2024, and will reach XX Million USD in 2028, with a CAGR of XX% during 2024-2028. days until july 5 2023WebJul 27, 2024 · Since March the company has surged from a share price of only 10¢ to 33¢, having climbed as high as 50¢ in May. Despite still being pre-revenue, the business is now valued at $1.6 billion. days until july 9th 2022WebJun 4, 2024 · Replimune currently has a market cap of US$ 740 million, $20.15 per share, so over $1 billion Aussie. Replimune currently has broker research /price targets of between $22 -$30 per share from analysts at JPMorgan, Roth Capital, Wainwright, Barclays . Ie median valuation of US$870 million gcp tech compliance program